The Tri-Cities Cancer Center Brings Advanced Cancer Treatment Option to Area Patients

Share Article

The Tri-Cities Cancer Center (TCCC) has purchased and installed a new Trilogy TM linear accelerator as a replacement for one of their current linear accelerators. This new radiotherapy system will allow them to treat patients with more complex cancers at their Kennewick facility. The new accelerator delivers radiation faster, more precisely, and with fewer side effects compared to conventional linear accelerators. The Center will now be able to offer treatment to cancer patients who would have previously been referred to facilities in Spokane or Seattle for care.

Tri-Cities Cancer Center patient and Dr. Shiela Rege

“This new technology gives us the tool we need to deliver on our promise of offering exceptional cancer treatment and support services."

The Tri-Cities Cancer Center (TCCC) has replaced one of their linear accelerators with a new radiotherapy system which will allow them to effectively treat patients with more complex cancers at their Kennewick facility. Their new Trilogy TM linear accelerator delivers radiation faster, more precisely, and with fewer side effects compared to conventional linear accelerators. This system offers intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT), as well as all other forms of external-beam radiation allowing the Center to offer treatment to cancer patients who would have previously been referred to Spokane or Seattle for care. For patients this means that they are now able to get the specific treatment that they need, while remaining close to family and friends through a challenging and often scary time.

While the Tri-Cities Cancer Center's current intensity-modulated radiotherapy (IMRT) units have been very effective in treating a variety of cancers, the addition of this new system offers the Center's team a wider breadth of tools to use when addressing each patient's specific treatment needs. The center purchased its Trilogy TM stereotactic linear accelerator from Varian Medical Systems, a leading provider in radiotherapy technology. The system can deliver all forms of external beam radiotherapy; 3D conformal radiotherapy, IMRT, stereotactic radiosurgery, fractionated stereotactic radiation therapy and intensity-modulated radiosurgery. This means that the Center is capable of treating a wider array of cancers, including; small lesions and metastases, larger tumors and cancers which are both intracranial and extracranial, using the most appropriate approach for each patient. Other positive benefits of the new equipment include; onboard imaging equipment, more precise treatment with reduced side effects, and a reduction in treatment time of about 60 percent, offering patients a more comfortable experience.

Tom Cothran, Executive Director of the Tri- Cities Cancer Center stated, "Bringing an advanced radiotherapy treatment option to the patient in their home community was a key factor when we decided to invest in this new technology. We recognize the struggle patients contend with when they must leave their support system of family and friends during their treatment." Cothran went on to say, "We've been providing cancer treatment in this community since 1994 and our focus has always been on providing exceptional treatment and support services to our patients, their families, and the community. This new technology gives us the tool we need to deliver on that promise".

To continue providing effective and efficient care the Center will continue to employ two treatment units, one IMRT specific unit as well as this new system. Within the next six months it is anticipated that the Center and its providers will begin utilizing even more capabilities of the Trilogy TM system including performing stereotactic radiosurgery.

Because their previous IMRT unit was still in good condition and as a way to make good use of their resources the Center chose to sell the unit through a brokerage to a hospital in Mexico, thus offering patients in that region of the world new radiation treatment options not previously available to them.

For more information visit the Tri-Cities Cancer Center website at http://www.tccancer.org. Inquires for follow-up interviews should be directed to Stephanie Williams at 509.948.3407.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stephanie Williams

Tom Cothran, Executive Director
Visit website